UniProt ID | NUFP1_HUMAN | |
---|---|---|
UniProt AC | Q9UHK0 | |
Protein Name | Nuclear fragile X mental retardation-interacting protein 1 | |
Gene Name | NUFIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 495 | |
Subcellular Localization | Nucleus . Distributed in the nucleus in a dot-like pattern. | |
Protein Description | Binds RNA.. | |
Protein Sequence | MAEPTSDFETPIGWHASPELTPTLGPLSDTAPPRDSWMFWAMLPPPPPPLTSSLPAAGSKPSSESQPPMEAQSLPGAPPPFDAQILPGAQPPFDAQSPLDSQPQPSGQPWNFHASTSWYWRQSSDRFPRHQKSFNPAVKNSYYPRKYDAKFTDFSLPPSRKQKKKKRKEPVFHFFCDTCDRGFKNQEKYDKHMSEHTKCPELDCSFTAHEKIVQFHWRNMHAPGMKKIKLDTPEEIARWREERRKNYPTLANIERKKKLKLEKEKRGAVLTTTQYGKMKGMSRHSQMAKIRSPGKNHKWKNDNSRQRAVTGSGSHLCDLKLEGPPEANADPLGVLINSDSESDKEEKPQHSVIPKEVTPALCSLMSSYGSLSGSESEPEETPIKTEADVLAENQVLDSSAPKSPSQDVKATVRNFSEAKSENRKKSFEKTNPKRKKDYHNYQTLFEPRTHHPYLLEMLLAPDIRHERNVILQCVRYIIKKDFFGLDTNSAKSKDV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAEPTSDFETPI ---CCCCCCCCCCCC | 32.22 | 24043423 | |
6 | Phosphorylation | --MAEPTSDFETPIG --CCCCCCCCCCCCC | 51.52 | 24043423 | |
10 | Phosphorylation | EPTSDFETPIGWHAS CCCCCCCCCCCCCCC | 21.87 | 26074081 | |
17 | Phosphorylation | TPIGWHASPELTPTL CCCCCCCCCCCCCCC | 13.15 | 26074081 | |
21 | Phosphorylation | WHASPELTPTLGPLS CCCCCCCCCCCCCCC | 16.74 | 26074081 | |
23 | Phosphorylation | ASPELTPTLGPLSDT CCCCCCCCCCCCCCC | 38.83 | 26074081 | |
28 | Phosphorylation | TPTLGPLSDTAPPRD CCCCCCCCCCCCCCC | 35.73 | 24043423 | |
30 | Phosphorylation | TLGPLSDTAPPRDSW CCCCCCCCCCCCCCC | 37.37 | 24043423 | |
126 | Methylation | YWRQSSDRFPRHQKS EEECCCCCCCCCHHH | 45.47 | 115485749 | |
133 | Phosphorylation | RFPRHQKSFNPAVKN CCCCCHHHCCHHHHC | 24.56 | 18187866 | |
189 | Phosphorylation | GFKNQEKYDKHMSEH CCCCHHHHHHHHHHH | 29.48 | 30301811 | |
194 | Phosphorylation | EKYDKHMSEHTKCPE HHHHHHHHHHCCCCC | 26.41 | 30301811 | |
205 | Phosphorylation | KCPELDCSFTAHEKI CCCCCCCCCCCCHHH | 25.87 | 25159151 | |
229 | Sumoylation | APGMKKIKLDTPEEI CCCCCCCCCCCHHHH | 49.54 | - | |
229 | Sumoylation | APGMKKIKLDTPEEI CCCCCCCCCCCHHHH | 49.54 | - | |
232 | Phosphorylation | MKKIKLDTPEEIARW CCCCCCCCHHHHHHH | 42.93 | 28674419 | |
247 | Phosphorylation | REERRKNYPTLANIE HHHHHHHCCCHHHHH | 10.71 | 25159151 | |
257 | Acetylation | LANIERKKKLKLEKE HHHHHHHHHHCCHHH | 70.34 | 69479 | |
260 | Acetylation | IERKKKLKLEKEKRG HHHHHHHCCHHHHHC | 64.58 | 88931 | |
265 | Acetylation | KLKLEKEKRGAVLTT HHCCHHHHHCCEEEE | 68.17 | 69483 | |
265 | Ubiquitination | KLKLEKEKRGAVLTT HHCCHHHHHCCEEEE | 68.17 | 24816145 | |
271 | Phosphorylation | EKRGAVLTTTQYGKM HHHCCEEEEHHHHCC | 22.62 | 20068231 | |
277 | Acetylation | LTTTQYGKMKGMSRH EEEHHHHCCCCCCCC | 32.29 | 25953088 | |
282 | Phosphorylation | YGKMKGMSRHSQMAK HHCCCCCCCCCHHHC | 35.19 | 22210691 | |
292 | Phosphorylation | SQMAKIRSPGKNHKW CHHHCCCCCCCCCCC | 41.29 | 20068231 | |
310 | Phosphorylation | NSRQRAVTGSGSHLC CCCCEECCCCCCCCC | 25.33 | 28555341 | |
312 | Phosphorylation | RQRAVTGSGSHLCDL CCEECCCCCCCCCCE | 27.97 | 25159151 | |
314 | Phosphorylation | RAVTGSGSHLCDLKL EECCCCCCCCCCEEE | 18.25 | 23312004 | |
338 | Phosphorylation | PLGVLINSDSESDKE CCCEEECCCCCCCCC | 35.20 | 26055452 | |
340 | Phosphorylation | GVLINSDSESDKEEK CEEECCCCCCCCCCC | 38.53 | 26055452 | |
342 | Phosphorylation | LINSDSESDKEEKPQ EECCCCCCCCCCCCC | 58.91 | 26055452 | |
351 | Phosphorylation | KEEKPQHSVIPKEVT CCCCCCCCCCCHHHH | 19.25 | 22115753 | |
358 | Phosphorylation | SVIPKEVTPALCSLM CCCCHHHHHHHHHHH | 12.16 | 30177828 | |
363 | Phosphorylation | EVTPALCSLMSSYGS HHHHHHHHHHHHCCC | 28.14 | 28102081 | |
366 | Phosphorylation | PALCSLMSSYGSLSG HHHHHHHHHCCCCCC | 26.21 | 28102081 | |
367 | Phosphorylation | ALCSLMSSYGSLSGS HHHHHHHHCCCCCCC | 21.39 | 28102081 | |
368 | Phosphorylation | LCSLMSSYGSLSGSE HHHHHHHCCCCCCCC | 11.92 | 28102081 | |
370 | Phosphorylation | SLMSSYGSLSGSESE HHHHHCCCCCCCCCC | 15.89 | 28102081 | |
372 | Phosphorylation | MSSYGSLSGSESEPE HHHCCCCCCCCCCCC | 41.80 | 28102081 | |
374 | Phosphorylation | SYGSLSGSESEPEET HCCCCCCCCCCCCCC | 34.28 | 28102081 | |
376 | Phosphorylation | GSLSGSESEPEETPI CCCCCCCCCCCCCCC | 61.21 | 28102081 | |
381 | Phosphorylation | SESEPEETPIKTEAD CCCCCCCCCCCCHHH | 28.75 | 28102081 | |
385 | Phosphorylation | PEETPIKTEADVLAE CCCCCCCCHHHHHHH | 36.81 | 29396449 | |
398 | Phosphorylation | AENQVLDSSAPKSPS HHCCCCCCCCCCCCC | 25.00 | 28450419 | |
399 | Phosphorylation | ENQVLDSSAPKSPSQ HCCCCCCCCCCCCCH | 48.54 | 22115753 | |
403 | Phosphorylation | LDSSAPKSPSQDVKA CCCCCCCCCCHHHHH | 28.82 | 30266825 | |
405 | Phosphorylation | SSAPKSPSQDVKATV CCCCCCCCHHHHHHH | 46.21 | 30266825 | |
411 | Phosphorylation | PSQDVKATVRNFSEA CCHHHHHHHHHHHHH | 17.80 | 26074081 | |
416 | Phosphorylation | KATVRNFSEAKSENR HHHHHHHHHHHHHHH | 39.95 | 26074081 | |
419 | Ubiquitination | VRNFSEAKSENRKKS HHHHHHHHHHHHHHH | 55.01 | 24816145 | |
420 | Phosphorylation | RNFSEAKSENRKKSF HHHHHHHHHHHHHHH | 47.34 | 26074081 | |
476 | Phosphorylation | VILQCVRYIIKKDFF HHHHHHHHHHHHHHC | 6.13 | 18669648 | |
487 | Phosphorylation | KDFFGLDTNSAKSKD HHHCCCCCCCCCCCC | 35.79 | 18669648 | |
489 | Phosphorylation | FFGLDTNSAKSKDV- HCCCCCCCCCCCCC- | 38.88 | 18669648 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NUFP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUFP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUFP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340; SER-342;TYR-476; THR-487 AND SER-489, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; SER-340 ANDSER-342, AND MASS SPECTROMETRY. |